Johnson & Johnson CEO Details Long-Term Oncology Growth Plan
June 12, 2026
Johnson & Johnson’s long-term plan to strengthen its position in oncology took center stage this week as Chief Executive Officer Joaquin Duato presented a strategy centered on business expansion, artificial intelligence adoption, and targeted acquisitions. Speaking about the company’s future direction, Duato said Johnson & Johnson intends to build on its existing cancer care portfolio while investing in technologies and partnerships designed to support growth across its pharmaceutical business. The executive’s comments outlined how the
